COMPASS PATHWAYS PLC Defined Contribution Plan, Cost
COMPASS PATHWAYS PLC (CMPS) reported Defined Contribution Plan, Cost of $200.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2023-02-28
- COMPASS PATHWAYS PLC defined contribution plan, cost for the quarter ending 2022-12-31 was $100.00K.
- COMPASS PATHWAYS PLC defined contribution plan, cost for the quarter ending 2022-09-30 was $0.00.
- COMPASS PATHWAYS PLC defined contribution plan, cost for the quarter ending 2022-06-30 was $0.00.
- COMPASS PATHWAYS PLC defined contribution plan, cost for the quarter ending 2022-03-31 was $100.00K, a 0.00% change year-over-year.
- COMPASS PATHWAYS PLC defined contribution plan, cost for fiscal 2022 was $200.00K, a 100.00% increase from fiscal 2021.
- COMPASS PATHWAYS PLC defined contribution plan, cost for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
- COMPASS PATHWAYS PLC defined contribution plan, cost for fiscal 2020 was $100.00K.
- COMPASS PATHWAYS PLC defined contribution plan, cost for fiscal 2019 was $0.00.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $100.00K derived: sum of 2 quarters · filed 2023-02-28 | $100.00K derived: sum of 3 quarters · filed 2023-02-28 | $200.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $100.00K 10-Q · filed 2022-11-03 | $100.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $100.00K 10-Q · filed 2022-08-04 | $100.00K derived: sum of 3 quarters · filed 2023-02-28 | $100.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-10 | $100.00K derived: sum of 2 quarters · filed 2023-02-28 | $100.00K derived: sum of 3 quarters · filed 2023-02-28 | $100.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $100.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $100.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $100.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $100.00K 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |